voriconazole has been researched along with ATLL in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Debets-Ossenkopp, YJ; van Furth, AM; van Groeningen, I; van Well, GT; Zwaan, CM | 1 |
| Gahn, B; Gramatzki, M; Repp, R; Schub, N | 1 |
2 other study(ies) available for voriconazole and ATLL
| Article | Year |
|---|---|
Zygomycete infection following voriconazole prophylaxis.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Drug Resistance, Fungal; Fatal Outcome; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Male; Microbial Sensitivity Tests; Pyrimidines; Rhizopus; Triazoles; Voriconazole; Zygomycosis | 2005 |
Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia-Lymphoma, Adult T-Cell; Lipopeptides; Liposomes; Male; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole | 2007 |